BAC — Bank of America Corporation

As of 2026-08-27 the tape is muted rather than euphoric: the stock is down 1.7% on the quoted session, RSI is 43.1, and price is below its 20-day moving average. The positive news flow (Q2 EPS beat, dividend hike to $0.32, Jio Financial JV) is being offset by limited implied upside to the consensus target of $66-67 and ongoing Fed/rate uncertainty.

FMP's gross revenue line is range-bound, roughly $46.7B-$49.7B over the past two years, but profitability has inflected sharply upward. Operating margin went from ~15.0-15.6% in 2024 to 23.4% in Q2 2026, and diluted EPS improved from $0.76-$0.83 in 2024 to $1.11-$1.20 in H1 2026. Q4 2025's operating-income spike with lower net income looks like an outlier; the 2025-2026 trend is broad margin expansion and higher normalized EPS, not a one-off blip.

Fairly valued, with a slight growth discount. As of 2026-08-27, BAC trades at roughly 13x trailing EPS (FMP's metric shows 13.9), versus a 5-year average of 12.25, and PEG is 0.51. Price-to-book is 1.45 on ~10% ROE, a reasonable multiple for a money-center bank, and the 2.08% dividend yield provides a modest floor.

The market is pricing BAC as a steady, mid-single-digit-to-high-single-digit grower, not a hot turnaround. Quarterly EPS is annualizing around $4.65-$4.80, so the stock is not discounting a boom; it's paying roughly a 13-14x multiple for improving but mature bank earnings. If Q3 2026 confirms NII stabilization, the stock can work toward the $66-67 analyst zone; if guidance disappoints, valuation has little cushion and the pullback could extend toward the low $50s.

As of 2026-08-27, RSI was 43.1—neutral, not oversold. Price was 3.0% below its 20-day SMA, 0.3% above its 50-day SMA (support around $61), and 12.1% above its 200-day SMA. That is a stalled uptrend pulling back to support rather than a confirmed breakdown; a move through $65.23 would resume the trend, while a close below the 50-day would be a short-term caution signal.

• Fed rate path: BAC's net interest income is sensitive to rate cuts; if deposits reprice faster than fixed-rate assets, NII gets squeezed.
• G-SIB surcharge and capital rules: higher required capital would reduce buyback capacity and pressure EPS growth.
• Credit cycle: commercial and consumer credit is stable, but a recession would elevate provisions and dent net income.
• Capital markets and deal flow: investment banking and wealth management fees add volatility around the core lending franchise.
• Yield curve shape: a steeper curve is a tailwind for lending margins; a flat/inverted curve remains a structural drag.

• Q3 2026 earnings on October 14, 2026: the market needs to see NII stabilization and continued fee momentum.
• Dividend ex-date September 4, 2026, and payment September 25, 2026 at the new $0.32 quarterly rate.
• Jio Financial joint venture: digital lending optionality in India, though near-term EPS impact is modest.
• Ongoing buybacks: strong capital generation and stress-test approval should support per-share growth.
• Any Fed signal on the terminal rate would trigger a repricing of NII expectations.

• Faster-than-expected rate cuts could compress NII and make the $4.645 forward EPS estimate too high.
• Consumer or commercial credit deterioration would force higher loan-loss provisions and hurt the 18% net margin.
• Regulatory capital increases (G-SIB surcharge) could slow buybacks and dividend growth.
• At 1.45x book and ~13x earnings, BAC is not priced for a negative surprise; a Q3 miss could push the stock back toward the $50s.
• Competitive pressure on deposit pricing and technology/buildout costs could cap margin expansion.

BAC is a good, not screaming-cheap, investment around $61-62 for a patient individual investor. Margins are expanding, earnings quality is clean (negative accruals ratio), capital returns are rising, and the stock trades near its historical multiple rather than at a premium; expected returns should come from steady EPS growth plus the 2.1% dividend, with modest repricing upside.

Applied a justified forward P/E of 14.0x to consensus forward EPS of $4.645, a modest premium to BAC's 5-year average multiple of 12.25x that reflects the 2024-2026 margin expansion and negative accruals. This yields $65.03 and is roughly consistent with 1.55x book value on ~$42/share equity, a fair price for a bank earning ~10% ROE.